Hemostasis, Surgical Bleeding, and Transfusions Flashcards
Describe Hemostasis after an injury?
5
- Vasoconstriction for about 60 seconds
- Next is platelets adhere to site of vascular injury
- After adhesion, platelets release adenosine diphosphate (ADP) causing platelet aggregation
- Formation of initial white thrombus
- Formation of permanent thrombus with fibrin
Coagulation pathway
1. Use of various coagulation factors to generate what?
- Extrinsic coagulation pathway
- Begins with what?
- Interacts with factors what? - Intrinsic coagulation pathway
- Requires which factors? - Common coagulation pathway
- Which factors? - Bleeding may occur with deficiency of any factors except factor what?
- fibrin
- thromboplastin
- VII to convert factor X to Xa
- Requires factors XII, XI, IX, and VIII to convert factor X to Xa
4.Involves factor X, V, II (prothrombin), and I (fibrinogen) Factor XIII (fibrin-stabilizing factor)
- XII
Evaluation of the patient
History
Most important step
Ask about medications specifically? 4
PE look for signs of what?
- OTC
- ASA
- Clopidogrel (Plavix)
- Warfarin (Coumadin)
Bleeding disorder
Evaluation of patient for high risk of bleeding
Test
5
- Platelet count
- Prothrombin time (PT)
- Partial thromboplastin time (PTT)
- Bleeding time
- Thrombin time
- Platelet count verifies what?
- If abnormal can order what?
- Normal platelet values?
- Verifies that an adequate number of platelets are available in the circulation
- blood smear to look at platelets under a microscope
- Normal values 150,00 – 400,000
- What does prothrombin time measure?
- Evaluates what factors? 5
- Which pathway? - Most common use for this lab?
- PT is reported as?
- Measures ability of the blood to form stable thrombi
- Evaluates factors VII, X, and V, prothrombin, and fibrinogen, and extrinsic pathway
- Most common use is monitoring Warfarin
- PT is reported with international normalized ratio (INR)
A ratio of a patient’s prothrombin time to a normal (control) sample
Partial Thromboplastin Time
- Evaluates what? 8
- Which pathway? - Most commonly used to monitor what?
- Normal in patients with what disorder?
- Evaluates adequacy of fibrinogen, prothrombin, factors V,VIII, IX, X, XI, XII, and intrinsic/common pathways
- Most commonly used to evaluate unfractionated heparin therapy
- Normal in patients with factor VII deficiency
- Describe the bleeding time procedure? 2
- Normal range?
- Prolonged time may indicate what? 3
- Two incisions with lancet on the forearm
- Time from injury to cessation of bleeding from both wounds is measured
- Normal range is 5-10 minutes
- Prolonged time may indicate;
- Thrombocytopenia
- Medication (ASA)
- Von Willebrand disease
UREMIA
- What does thrombin time evaluate?
2. Prolongations means? 4
- Evaluates fibrinogen-to-fibrin conversion with an external source of thrombin
- Prolongation;
- Low fibrinogen levels
- Abnormal fibrinogen
- Fibrin and fibrinogen split products
- Heparin
DIC and Chronic liver disease too
Surgical bleeding
- Patients can loose large volumes of blood from generalized oozing post-op
- Some operations are associated with large blood loss
Preexisting hemostatic defects
that make patients at risk for bleeding? 3
- Congenital bleeding disorders
- Acquired bleeding disorders
- Medication-Associated Bleeding
Congenital Bleeding Disorders: Von Willebrand Disease 1. Pathophysiology? 2. Site of bleeding 3. Inheritance 4. Lab studies? 3
- Reduced factor VIII activity and von Willebrand activity
- Mucocutaneous
- Autosomal dominant
- Prolonged PTT
- Normal PT
- Abnormal platelet function
Von Willebrand
Tx?
2
- Cryoprecipitate infusions
2. Desmopressin (DDAVP)
Congenital bleeding disorders
Hemophilia A
1. Pathophysiology?
2. Site of bleeding?
- Gender?
- Labs? 3
- Treatment?
- Reduced or absent factor VIII activity
- Joints and intramuscular
- Only males
- Prolonged PTT
- Normal PT
- Normal platelet function
- Purified factor VIII products
Acquired bleeding disorders
More common than congenital bleeding disorders
Causes? 5
- Advanced liver disease
- Anticoagulation therapy
- Acquired thrombocytopenia
- Platelet-inhibiting drugs
- uremia
Acquired bleeding disorder
Liver disease- Common cause
1. PP?
2. Which factors are affected? 4
- What may lead to clotting factor deficiencies? 2
- Respond well to what?
- Inability to synthesize proteins leads to decreased levels of
- prothrombin and factors V, VII, and X
- Obstructive jaundice
- Cirrhosis
- vitamin K
Anticoagulation therapy
Warfarin (Coumadin)
1. Depression of what factors? 4
- Reversed how? 2
Heparin
3. Increased speed of antithrombin III binds to and neutralizes factors what? 5
- Reversed with?
- Depression of clotting factors II, VII, IX, X
- Can be reversed with fresh frozen plasma (FFP) or vitamin K in an emergency
- IXa, Xa, Xia, XIIa, and thrombin
Prolongs PTT and thrombin time - Reversed with protamine sulfate
Acquired thrombocytopenia
3 mechanisms
- Decreased platelet production in bone marrow
- Increased destruction of platelets in peripheral blood
- Splenic pooling in enlarged spleen
Platelet Inhibiting drugs? 3
-When should these be stopped before surgery?
Platelet-inhibiting drugs 1. ASA Should stop 1 week before surgery 2. Clopidogrel (Plavix) Should be stopped 7-10 days before surgery 3. NSAIDs
Uremia
- Causes what?
- Patients who are bleeding and need surgery require what to correct platelet dysfunction?
- Platelet dysfunction
2. dialysis